lung injury
CONCLUSIONS: IGFBP-5, IGF-1 and TGF-b1 in the type II AECs play a key role in lung injury caused by bleomycin and pioglitazone attenuates the lung injury/fibrosis by restoring IGFBP-5 and IGF-1 and decreasing TGF-b1 expressions in the type II AECs.